Arena Pharmaceuticals submits lorcaserin NDA to the FDA Arena Pharmaceuticals, Inc. announced today that it has submitted a New Drug Program to the US Food and Medication Administration for lorcaserin, Arena’s internally found out and developed medication candidate for weight reduction, including pounds maintenance and loss of weight loss http://mebeverine.org/usage-of-colofac.html . The submission is founded on an extensive data bundle from lorcaserin’s clinical advancement program which includes 18 scientific trials totaling 8,576 sufferers. Related StoriesStudy reveals potential limitations of app-based approach to excess weight lossPoverty and parenting style predict childhood obesityNegative body image significantly increases weight problems risk among adolescentsWilliam R.
This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family members Foundation. Kaiser Health Information, an unbiased news service editorially, is a program of the Kaiser Family members Foundation, a nonpartisan health care policy research company unaffiliated with Kaiser Permanente.. Ariz. Governor announces plan to cut Medicaid but restore some transplant funding Gov. Jan Brewer asks HHS to approve proposal that would lower some enrollees and increase their cost sharing. Modern Healthcare: Ariz. Governor Seeks 5-Calendar year Medicaid Waiver Arizona Gov. Jan Brewer is requesting HHS for a five-year waiver to lessen Medicaid rolls and boost member cost-posting but also restore some organ transplant benefits.